Immage Systems Low Concentration Immunoglobulin A Reagent
Iga, Antigen, Antiserum, Control. 510(k) K060130, from Beckman Coulter, Inc. (Brea, CA). Product code CZP, class 2.
As of Nov 19, 2026, K060130 is an FDA 510(k) held by Beckman Coulter, Inc., substantially equivalent on Feb 13, 2006 after 26 days, with no recalls tied to it in FDA's recall database.
- Review time: 26 days
- Recalls: 0
INTENDED USE IGALC reagent, when used in conjunction with IMMAGE® Immunochemistry Systems and Cerebrospinal Fluid Protein Calibrator, is intended for quantitative determination of Low Concentration Immunoglobulin A (IGALC) in human serum or cerebrospinal fluid (CSF) by rate nephelometry.
- Beckman Coulter Immage Immunochemistry System Low Concentration Immunoglobulin A (Igalc) Reagent, Beckman Coulter CerebrK993549 · Beckman Coulter, Inc. · Feb 1, 2000
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Jan 18, 2006
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5510
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files